Group One Trading
PGNX

Group One Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Group One Trading’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,000
Closed -$15K – 6473
2020
Q1 		$15K Sell
4,000
-82,800
-95% -$357K ﹤0.01% 4402
2019
Q4 		$442K Buy
86,800
+31,800
+58% +$168K ﹤0.01% 2535
2019
Q3 		$278K Buy
55,000
+45,000
+450% +$224K ﹤0.01% 2838
2019
Q2 		$62K Sell
10,000
-1,000
-9% -$4.82K ﹤0.01% 3666
2019
Q1 		$51K Sell
11,000
-65,900
-86% -$298K ﹤0.01% 3561
2018
Q4 		$323K Sell
76,900
-27,200
-26% -$138K ﹤0.01% 2321
2018
Q3 		$653K Buy
104,100
+56,600
+119% +$435K 0.01% 2049
2018
Q2 		$382K Sell
47,500
-46,000
-49% -$351K ﹤0.01% 2525
2018
Q1 		$698K Buy
93,500
+19,900
+27% +$132K 0.01% 1779
2017
Q4 		$438K Buy
73,600
+30,900
+72% +$188K ﹤0.01% 2354
2017
Q3 		$314K Buy
42,700
+18,000
+73% +$114K ﹤0.01% 2433
2017
Q2 		$168K Sell
24,700
-30,500
-55% -$225K ﹤0.01% 2772
2017
Q1 		$521K Buy
55,200
+38,800
+237% +$387K 0.01% 1827
2016
Q4 		$142K Sell
16,400
-65,900
-80% -$487K ﹤0.01% 2631
2016
Q3 		$521K Buy
82,300
+61,500
+296% +$372K 0.01% 1792
2016
Q2 		$88K Sell
20,800
-41,400
-67% -$200K ﹤0.01% 2951
2016
Q1 		$271K Buy
62,200
+32,400
+109% +$144K ﹤0.01% 2126
2015
Q4 		$183K Sell
29,800
-1,200
-4% -$7.87K ﹤0.01% 2557
2015
Q3 		$177K Sell
31,000
-16,100
-34% -$124K ﹤0.01% 2593
2015
Q2 		$351K Sell
47,100
-16,000
-25% -$96.8K ﹤0.01% 2095
2015
Q1 		$377K Buy
63,100
+55,400
+719% +$349K 0.01% 1847
2014
Q4 		$58K Buy
7,700
+5,300
+221% +$31.7K ﹤0.01% 3276
2014
Q3 		$12K Sell
2,400
-2,400
-50% -$12K ﹤0.01% 4396
2014
Q2 		$21K Sell
4,800
-27,400
-85% -$105K ﹤0.01% 4135
2014
Q1 		$132K Sell
32,200
-800
-2% -$4.09K ﹤0.01% 2811
2013
Q4 		$176K Sell
33,000
-3,100
-9% -$13.6K ﹤0.01% 2550
2013
Q3 		$182K Sell
36,100
-16,200
-31% -$87.9K ﹤0.01% 2467
2013
Q2 		$233K Buy
+52,300
New +$235K 0.01% 2040

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Group One Trading's PGNX Position: Q2 2020 in Review

Group One Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 9,478 shares — an estimated $36K sold.

Group One Trading first reported a position in PGNX in Q2 2013 and held it in 20 quarters. The position peaked at $511K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Group One Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 9,478 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $36K.
  • Group One Trading first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
  • Group One Trading's Progenics Pharmaceuticals Inc position peaked at $511K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.